Marburg virus vaccines: comparing classical and new approaches.
about
Alphavirus-based vaccinesMouse models for filovirus infectionsVaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus InfectionsProtective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteinsEbola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.DNA vaccines for biodefense.Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.Ebola virus-like particles protect from lethal Ebola virus infection.Alphavirus vectors for vaccine production and gene therapy.Advances in virus-like particle vaccines for filoviruses.Filovirus vaccines.Developments in hepatitis C therapy during 2000-2002.Defensive applications of gene transfer technology in the face of bioterrorism: DNA-based vaccines and immune targeting.Prospects for immunisation against Marburg and Ebola viruses.Filovirus-like particles as vaccines and discovery tools.Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challengesEpidermal delivery of protein and DNA vaccines.Forty-five years of Marburg virus research.Development of vaccines for Marburg hemorrhagic fever.Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).Technical transformation of biodefense vaccines.Fibroblastic reticular cells and their role in viral hemorrhagic fevers.Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.Self-replicating alphavirus RNA vaccines.Small Animal Models for Studying Filovirus Pathogenesis.Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques.High-throughput virtual screening and docking studies of matrix protein vp40 of ebola virus.Future Approaches to DNA Vaccination Against Hemorrhagic Fever Viruses.
P2860
Q26994724-307C9DCE-28C6-4D1E-8413-27202DC96F76Q27011569-B7FB0F44-B3D3-4327-8364-4A239222FD7AQ27485491-C6E42333-D026-4218-9005-2D5401257893Q34123838-023A75B1-E710-46ED-9B1A-9CCE5A8AA11BQ34583832-C271ED56-C902-4816-BA6F-1394FDA6EBA9Q34614260-3312B029-C66A-43D9-BDFA-B0071A1E565BQ34774783-0A158E94-62E2-49C2-B56C-44AADCE33244Q34792924-62637100-E352-4BEC-8314-AFD847088CB7Q35194202-054C5D55-B7D6-458F-92E1-C92AA6556E79Q35300029-8F7CB585-E187-4F4F-BF86-1C463CF621F7Q35558539-E2316C4D-D87E-4B56-83D1-4B38646E5F44Q35581123-646CAB13-6FC6-458B-9C97-CD65D1F73176Q35594090-39B63F6A-4E0A-4E35-974C-6648BEA65E56Q36088118-16B0FC44-2288-4D8A-A83D-F148F7D77C31Q36198685-E0017B8A-95FF-46C2-952B-9F06BABA78D8Q36255716-B1B2C5A0-5DBB-4C6E-BD67-3A0B6B13B04CQ36316708-82CF468F-FBD8-421B-8890-47DE35C9D508Q36395831-9342F68E-8E7A-4F8F-98CB-CC619FFCDCEAQ36728793-98D34445-7791-4C6E-BBAD-62E34B5AFCB1Q36845999-1DB976C2-6284-4488-8E14-BF8116A546DBQ37058898-7A42E86D-CCAD-4360-8123-6F23876BA4AEQ37463214-C0D9909D-47CE-4C12-AF23-650D92F3FC0CQ37976671-5B248B2A-D323-41EC-A07A-FED12433D224Q38255634-77923203-626A-4793-A08F-9158679D9A38Q38666317-1AB12BE6-74DF-4FAB-BC2E-F39B6D594994Q38840884-AE43BAF2-645C-4385-A1E5-7BF702BF2C97Q39259533-ACB13B0D-F2BA-477C-8096-08FA4DC5CDDAQ41922339-686407DB-E6A8-4ECE-A468-D01D701FD786
P2860
Marburg virus vaccines: comparing classical and new approaches.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Marburg virus vaccines: comparing classical and new approaches.
@ast
Marburg virus vaccines: comparing classical and new approaches.
@en
Marburg virus vaccines: comparing classical and new approaches.
@nl
type
label
Marburg virus vaccines: comparing classical and new approaches.
@ast
Marburg virus vaccines: comparing classical and new approaches.
@en
Marburg virus vaccines: comparing classical and new approaches.
@nl
prefLabel
Marburg virus vaccines: comparing classical and new approaches.
@ast
Marburg virus vaccines: comparing classical and new approaches.
@en
Marburg virus vaccines: comparing classical and new approaches.
@nl
P2093
P1433
P1476
Marburg virus vaccines: comparing classical and new approaches.
@en
P2093
Geisbert J
Jahrling PB
Schmaljohn AL
Schmaljohn C
Tammariello RF
VanderZanden L
P304
P356
10.1016/S0264-410X(01)00353-X
P407
P577
2001-11-01T00:00:00Z